000 01386 a2200385 4500
005 20250516193008.0
264 0 _c20141118
008 201411s 0 0 eng d
022 _a1569-8041
024 7 _a10.1093/annonc/mdt592
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHamaker, M E
245 0 0 _aOn-going clinical trials for elderly patients with a hematological malignancy: are we addressing the right end points?
_h[electronic resource]
260 _bAnnals of oncology : official journal of the European Society for Medical Oncology
_cMar 2014
300 _a675-681 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAging
650 0 4 _aClinical Trials as Topic
_xmethods
650 0 4 _aDelivery of Health Care
650 0 4 _aFemale
650 0 4 _aHematologic Neoplasms
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOutcome Assessment, Health Care
650 0 4 _aQuality of Life
650 0 4 _aResearch Design
650 0 4 _aTreatment Outcome
700 1 _aStauder, R
700 1 _avan Munster, B C
773 0 _tAnnals of oncology : official journal of the European Society for Medical Oncology
_gvol. 25
_gno. 3
_gp. 675-681
856 4 0 _uhttps://doi.org/10.1093/annonc/mdt592
_zAvailable from publisher's website
999 _c23480566
_d23480566